Carlsmed, a San Diego-based medical technology company that’s developing personalized spinal implants, has merged with Precisive Surgical, a spine imaging system startup in Seattle.
The combined company, which will operate in San Diego under the Carlsmed name, aims to create a... Read more »
In late 2017, a federal watchdog unit assigned a working group to keep an eye on cryptocurrencies such as Bitcoin, and to sound an alert if those alternate currencies showed signs of becoming a risk to the stability of the US... Read more »
The opioid crisis reaches all corners of the nation, and newly released data this week revealed how the growth of the epidemic tracked with a massive increase in the production and distribution of these drugs.
From 2006 to 2012, the number... Read more »
Comic-Con International may be holding everyone’s attention this week, but the tech community has stayed busy amid all the action (and increased traffic). Let’s catch up with the latest tech news in San Diego.
—San Diego’s AONDevices was among 10 startups... Read more »
Initial public offerings took a brief summer break the week of Independence Day, but healthcare IPO activity resumed this week as three more companies joined the US public markets. Here’s a recap of the biotech companies that priced IPOs Wednesday evening.... Read more »
Trefoil Therapeutics, which is developing treatments for diseases that affect the cornea, the outermost layer of the eye, has raised $28 million to move its lead drug candidate into human testing.
The company is developing an engineered form of fibroblast growth... Read more »
Another company headed by former Illumina executives has launched, fueled with a $17 million Series A round from investors including a local venture capital firm.
The new firm, Cradle Genomics, is seeking to commercialize improved non-invasive prenatal tests, which analyze blood... Read more »
The life science and healthcare worlds are vast. We often talk about impact in terms of millions of patients and billions of dollars. But these worlds can be small, too. It seems at times we’re never far removed from any one... Read more »
Amgen and Novartis are stopping work on an experimental Alzheimer’s disease drug after an early look at clinical data showed worsening cognitive function in patients.
The interim results announced Thursday were part of a pre-planned review of data from two pivotal... Read more »
Donald Trump’s criticism of high drug prices began during the 2016 presidential campaign and continued through his presidency, perhaps most famously just before his inauguration when he said that drug companies were “getting away with murder.”
This week has... Read more »
More than a third of the companies that went public in the first half of this year were backed by venture capital.
That, plus robust merger and acquisition activity, set a record for venture-backed exit value—$165.2 billion in money returned to... Read more »
Eight years after San Diego biotech Prometheus Laboratories was acquired by Nestlé Health Science, the diagnostic business has been sold again, this time to a little-known biotech called Precision IBD that plans to lay off approximately a quarter of Prometheus’s... Read more »
[Editor’s note: This is part of a series examining the internet’s first 50 years and predicting the next half century. Join Xconomy and World Frontiers Forum on July 16 for Net@50, an event exploring the internet’s past and future.... Read more »